Facebook tracking pixel
I70.213
ICD-10-CM
Aortoiliac Occlusive Disease

Understanding Aortoiliac Occlusive Disease (Aortoiliac Disease, Leriche Syndrome): Find information on diagnosis, treatment, and clinical documentation for Aortoiliac Occlusive Disease. This resource covers medical coding, healthcare guidelines, and relevant terms for Aortoiliac Disease and Leriche Syndrome. Learn about symptoms, diagnostic criteria, and management strategies for Aortoiliac Occlusive Disease from a clinical perspective.

Also known as

Aortoiliac Disease
Leriche Syndrome

Diagnosis Snapshot

Key Facts
  • Definition : Narrowing or blockage of the aorta and iliac arteries, reducing blood flow to the legs and pelvis.
  • Clinical Signs : Leg pain (claudication), buttock pain, erectile dysfunction, absent femoral pulses.
  • Common Settings : Vascular surgery clinics, cardiology, interventional radiology.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC I70.213 Coding
I70-I79

Diseases of arteries, arterioles and capillaries

Covers various arterial diseases, including aortoiliac occlusive disease.

I70.2

Atherosclerosis of aorta

Specifically relates to atherosclerosis in the aorta, a key component of aortoiliac disease.

I73.9

Peripheral vascular disease, unspecified

A broader category that may be used when a more specific aortoiliac code isn't available.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the aortoiliac occlusion due to atherosclerosis?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Peripheral artery disease affecting the aorta and iliac arteries.
Peripheral artery disease affecting lower extremities, excluding aorta/iliac.
Chronic, progressive narrowing of abdominal aorta and its branches.

Documentation Best Practices

Documentation Checklist
  • Document location, severity, and laterality of aortoiliac occlusion.
  • Specify Leriche syndrome if classic triad present (claudication, impotence, absent femoral pulses).
  • Record ABI measurements and imaging findings (e.g., CTA, MRA).
  • Note symptoms: claudication, rest pain, erectile dysfunction.
  • Detail treatment plan: conservative management, intervention, or surgery.

Coding and Audit Risks

Common Risks
  • Code Specificity

    Aortoiliac disease may involve different segments. Coding should specify the location (e.g., aorta, iliac arteries) for accurate reimbursement.

  • Clinical Validation

    Leriche syndrome requires confirming characteristic symptoms. Documentation must support the diagnosis to avoid clinical validation denials.

  • Laterality Documentation

    If disease impacts one side, document laterality (right, left, bilateral). Missing laterality can lead to coding errors and claim rejections.

Mitigation Tips

Best Practices
  • Document claudication symptoms, ABI scores for ICD-10 I70.2
  • Capture Leriche triad for improved CDI, HCC coding accuracy
  • Specify disease location (aorta, iliac) in operative reports
  • Code comorbidities like hypertension, diabetes with I70.2
  • Review medical necessity for interventions, ensure compliance

Clinical Decision Support

Checklist
  • Verify diminished femoral pulses (ICD-10 I70.2)
  • Confirm claudication symptoms in buttocks, thighs (SNOMED CT 440.2)
  • Check for erectile dysfunction, impotence (ICD-10 N52.9)
  • Assess ankle-brachial index ABI < 0.9 (LOINC 44814-3)

Reimbursement and Quality Metrics

Impact Summary
  • Aortoiliac Occlusive Disease reimbursement hinges on accurate ICD-10 coding (I70.2) and supporting documentation for optimal payer reimbursements.
  • Coding quality impacts Aortoiliac Disease metrics reporting, affecting hospital quality scores and potential value-based payments.
  • Precise Leriche Syndrome coding ensures proper DRG assignment, influencing hospital reimbursement and resource allocation.
  • Aortoiliac disease coding accuracy directly impacts vascular surgery service line data reporting and performance analysis.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What are the key differentiating diagnostic features between aortoiliac occlusive disease and other causes of lower extremity claudication in older adults?

A: Differentiating aortoiliac occlusive disease (AIOD, also known as Leriche syndrome) from other causes of lower extremity claudication, such as lumbar spinal stenosis or peripheral artery disease (PAD) isolated to the femoropopliteal segment, requires a thorough clinical assessment. In AIOD, claudication pain often involves the buttocks, hips, and thighs, a symptom less common in other conditions. Absent or diminished femoral pulses are a hallmark of AIOD, while patients with spinal stenosis typically have normal pulses. Furthermore, patients with AIOD may experience erectile dysfunction (Leriche syndrome triad), a symptom not typically associated with other forms of claudication. Advanced imaging studies, like CT angiography or MR angiography, are crucial for confirming the diagnosis and delineating the extent of the occlusion. Explore how different imaging modalities can aid in differentiating these conditions and guiding treatment decisions.

Q: How do I effectively manage a patient with aortoiliac occlusive disease and comorbidities like diabetes and hypertension, considering both medical and surgical treatment options?

A: Managing a patient with aortoiliac occlusive disease (AIOD) and comorbidities like diabetes and hypertension requires a multidisciplinary approach. Aggressive risk factor modification is paramount, including optimizing blood pressure and glycemic control, promoting smoking cessation, and managing dyslipidemia. Initial medical therapy typically involves antiplatelet agents and medications to address claudication symptoms, such as cilostazol. For patients with lifestyle-limiting claudication or critical limb ischemia, surgical intervention, such as aortoiliac endarterectomy, bypass grafting, or percutaneous transluminal angioplasty (PTA), may be necessary. The choice between these procedures depends on the patient's overall health, the extent and location of the occlusion, and anatomical considerations. Consider implementing a collaborative care pathway involving vascular specialists, endocrinologists, and other relevant specialists to personalize the treatment strategy. Learn more about the latest evidence-based guidelines for managing AIOD in patients with complex comorbidities.

Quick Tips

Practical Coding Tips
  • Code I70.261 for Aortoiliac
  • Document claudication symptoms
  • Specify location, laterality
  • Query MD if Leriche suspected
  • Check for coexisting PAD

Documentation Templates

Patient presents with symptoms suggestive of aortoiliac occlusive disease (AIOD), also known as aortoiliac disease or Leriche syndrome.  The patient reports intermittent claudication characterized by pain, cramping, or fatigue in the buttocks, thighs, and calves during exercise, relieved by rest.  Physical examination reveals diminished or absent femoral pulses, cool lower extremities, and potential signs of lower extremity ischemia such as pallor or dependent rubor.  The patient's medical history includes risk factors for atherosclerosis, such as hypertension, hyperlipidemia, smoking, and diabetes.  Differential diagnoses include lumbar spinal stenosis, peripheral neuropathy, and popliteal artery disease.  Diagnostic workup may include ankle-brachial index (ABI) measurement, duplex ultrasonography of the aortoiliac arteries, computed tomography angiography (CTA), or magnetic resonance angiography (MRA) to assess the degree of arterial stenosis or occlusion.  Treatment options for aortoiliac occlusive disease include lifestyle modifications such as smoking cessation, supervised exercise therapy, and pharmacologic management with antiplatelet agents and statins.  For significant stenosis or occlusion, interventions such as percutaneous transluminal angioplasty (PTA) with or without stenting, or aortofemoral bypass surgery may be considered.  The patient was counseled on the importance of risk factor modification and follow-up care.  Further evaluation and management will be based on the results of diagnostic imaging and the patient's response to initial therapy.  ICD-10 code I70.20, atherosclerotic occlusion of aorta, unspecified, and CPT codes for relevant diagnostic and therapeutic procedures will be documented accordingly.